The optimal dose of Ramelteon for the better treatment adherence of delayed sleep–wake phase disorder: a dropout rate study

BACKGROUND: Evidence regarding the effectiveness of melatonin receptor agonists in treating delayed sleep–wake phase disorder (DSWPD) remains limited. This study aimed to determine the optimal dose of ramelteon, a melatonin receptor agonist, for the better treatment adherence of DSWPD. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Takagi, Shunsuke, Sugihara, Genichi, Takahashi, Hidehiko, Inoue, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568065/
https://www.ncbi.nlm.nih.gov/pubmed/37840911
http://dx.doi.org/10.3389/fneur.2023.1280131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568065/
https://www.ncbi.nlm.nih.gov/pubmed/37840911
http://dx.doi.org/10.3389/fneur.2023.1280131

Ejemplares similares